Skip to main content
TTrialFinder
TrialFinder is for informational purposes only and does not provide medical advice. Always talk to your doctor.
RECRUITINGINTERVENTIONAL

Study With a Newly Optical Coherence Tomography Probe for Optimizing Bladder Cancer Diagnosis and Treatment

IDEAL Phase II Study of a Newly Designed Optical Coherence Tomography Probe During Transurethral Resection for Optimizing Bladder Cancer Diagnosis and Treatment

Important: This information is not medical advice. Talk to your doctor about whether a clinical trial is right for you.

About This Trial

The goal of this clinical trial is to see if a new designed optical coherence tomography catheter can be used in bladder cancer in patients undergoing a transurethral resection of a bladder tumour. The main question it aims to answer is: \- Is the optical coherence tomography catheter feasible in capturing images of bladder tumours and normal bladder wall during a transurethral resection of a bladder tumour? Participants will undergo measurements with a new optical coherence tomography device during the transurethral resection of their bladder tumour(s).

Who May Be Eligible (Plain English)

Who May Qualify: - Age \> 18 years. - Have at least 1 suspected bladder tumour seen at cystoscopy. - Have a bladder that is accessible for cystoscopy. - Be in a physical condition to undergo a TURBT. - Eligible patients must be fully informed about the study and written signed willing to sign a consent form must be obtained prior to any study related investigation/intervention. Who Should NOT Join This Trial: - Pregnant or lactating women. - The only tumour site is at the bladder neck. - The tumour(s) is larger than 2 centimetres in diameter. - \>5 tumours present. - Solely a suspected flat lesion present. Always talk to your doctor about whether this trial is right for you.

Original Eligibility Criteria

View original clinical language
Inclusion Criteria: * Age \> 18 years. * Have at least 1 suspected bladder tumour seen at cystoscopy. * Have a bladder that is accessible for cystoscopy. * Be in a physical condition to undergo a TURBT. * Eligible patients must be fully informed about the study and written signed informed consent must be obtained prior to any study related investigation/intervention. Exclusion Criteria: * Pregnant or lactating women. * The only tumour site is at the bladder neck. * The tumour(s) is larger than 2 centimetres in diameter. * \>5 tumours present. * Solely a suspected flat lesion present.

Treatments Being Tested

DEVICE

Optical coherence tomography

Measurement with opctical coherence tomography of tumour and normal bladder tissue during transurethral resection of a bladder tumour (TURBT)

Locations (2)

Amsterdam University Medical Center
Amsterdam, North Holland, Netherlands
Amsterdam University Medical Center
Amsterdam, Netherlands